where imu stands in this swine flu outbreak, page-2

More to add:

Avian Influenza Vaccine Market

• Currently, the USDA maintains a bank of 40 million doses of avian influenza vaccine for use in birds and is currently expanding the bank by another 30 million additional doses. In addition, the European Commission adopted new legislation in December 2005 for vaccination of poultry from farms with confirmed low pathogenic influenza (Dir/94/EC) to be implemented by 1 July 2007. Italy, France and The Netherlands are currently vaccinating. The Chinese government announced plans in 2005 to vaccinate all 14 billion of its farm birds.
• A ‘non-vectored’ sub-unit coccidia vaccine is currently sold by Abic for the breeder market (1.4 billion birds in 2005). However, it is expensive and laborious to administer this vaccine as it requires injection. As the Imugene Vector Delivery System vaccine does not require injection, it is ideal for mass administration to many thousands of birds via their drinking water or via aerosol using minimal labour. Thus the vaccine can potentially be used in the much larger broiler market.

Pig Health Product and Vaccine Market

• The USA and Europe, followed by Asia, are the key target markets for any new pig product. Although Asia has the largest population of pigs followed by the European Union and the Americas (North, Central and South), the USA and Europe are the largest markets for pig animal health products, with the USA market approaching US$1 billion per year
• The global market for biological products is projected to grow substantially over the next 5 years while at the same time medicinal feed additive markets (antibiotics) are projected to significantly reduce. This growth in the biologicals market will include new vaccines for emerging diseases such as Porcine Respiratory & Reproductive Syndrome (PRRS) and biological productivity enhancers replacing in-feed antibiotics.

Now Swine Flu!!!!